Preparation and Reactivities of PCP-Type Pincer Complexes of Nickel. Impact of Different Ligand Skeletons and Phosphine Substituents
摘要:
Reaction of the diphosphine ligand i-Pr2P(CH2)(5)P(i-Pr)(2) with NiBr2 at 110 degrees C gives a mixture of the 16-membered bimetallacycle {i-Pr2(P)(CH2)SP(i-Pr)(2)}(2)Ni2Br4, 1, and the pincer-type complex {(i-Pr2PCH2CH2)(2)CH}NiBr, 2; the latter can also be obtained by heating 1 in the presence of 4-(dimethylamino)pyridine or under vacuum. Complex 2 undergoes transmetalation with RMgCl or RLi to give {(i-Pr2PCH2CH2)(2)CH}NiR (R = Me (4), C CMe (5), Ph (6), n-Bu (7), and C CPh (8)); the phenylacetylide derivative 8 was also obtained from the reaction of PhC CH with 4, 5, or 7. The Ni-Me derivative 4 reacts with PhX (X = I, Br, Cl) to give the product of C-C coupling reaction (Ph-Me) and the Ni-X analogues of 2, and tests have shown that 2 is a competent catalytic precursor for the coupling of PhCl and MeMgCl. The available evidence suggests that this catalytic process does not involve Ni intermediates. Indeed, cyclic voltammetry measurements show that 2 can undergo two consecutive oxidations, and attempts to generate isolable high-valent species yielded the five-coordinate, 17-electron Ni-III species {(i-Pr2PCH2CH2)(2)CH}NiX2, 9, from the reaction of 2 with FeX3 (X = Cl, Br). Characterization of all new complexes, including X-ray diffraction studies on single crystals of complexes 1-6 and 9, is described.
The present disclosure provides processes for the preparation of a compound of formula:
which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates.
[EN] PROCESSES FOR PREPARING ANTIVIRAL COMPOUNDS<br/>[FR] PROCÉDÉS DE PRÉPARATION DE COMPOSÉS ANTIVIRAUX
申请人:GILEAD PHARMASSET LLC
公开号:WO2015191437A1
公开(公告)日:2015-12-17
The present disclosure provides processes for the preparation of a compound of formula: which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates.
The present disclosure provides processes for the preparation of a compound of formula:
which is useful as an antiviral agent. The disclosure also provides compounds that are synthetic intermediates.
The diphosphine proligand R2P(CH2)(5)PR2 (R = i-Pr) reacts with PdCl2 or Pd(PhCN)(2)Cl-2 in CH2Cl2 to give the 2:2 adduct trans-mu-k(P),k(P') -R2P(CH2)(5)PR2}(2)Pd2Cl4 (1) featuring a 16-atom chelate ring, along with other uncharacterized species. Treating 1 with AgOTf or heating it in the solid state gave the PCsp3P-type pincer complexes k(P),k(C),k(P)-(R2P(CH2)(2))(2)CH}PdX (X: OTf, 2; Cl, 2-Cl). Complex 2 was also prepared via a one-pot route by refluxing a mixture of the proligand, PdCl2, and AgOTf in toluene. Complexes 1 and 2 have been characterized by NMR spectroscopy, elemental analysis, mass spectrometry and single crystal X-ray analysis. (C) 2020 Elsevier Ltd. All rights reserved.